Vertical and Horizontal Mandibular Ridge Augmentation Techniques
NCT ID: NCT06636084
Last Updated: 2025-07-25
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
WITHDRAWN
NA
INTERVENTIONAL
2025-12-01
2027-06-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Vertical Ridge Augmentation With Autogenous Onlay Blocks Combined With Guided Bone Regeneration Versus Autogenous Bone Graft With Titanium Mesh in Posterior Mandible
NCT03680118
Customized Titanium Membrane for Growing Jaw Bone Horizontally
NCT02227719
Comparing the Efficacy and Morbidity of Two Vertical Ridge Augmentation Techniques
NCT02703480
Vertical Ridge Augmentation Strategies
NCT06242782
Three-dimensional Bone Regeneration Using Custom-made Meshes With and Without Collagen Membrane
NCT04286334
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Customized CAD/CAM Titanium Mesh
A customized CAD/CAM Titanium Mesh will be used to cover the bone graft
Guided bone regeneration (GBR)
A composite graft composed of a 50:50 proportion of autogenous bone and a demineralized bone mineral will be positioned around the bony defect or placed in the membrane, depending on the group randomization. The selected membrane will then be secured with screws to ensure a complete and stable coverage of the grafted area.
Reinforced Perforated PTFE Mesh (RPM)
A Reinforced Perforated PTFE Mesh membrane will be used to cover the bone graft
Guided bone regeneration (GBR)
A composite graft composed of a 50:50 proportion of autogenous bone and a demineralized bone mineral will be positioned around the bony defect or placed in the membrane, depending on the group randomization. The selected membrane will then be secured with screws to ensure a complete and stable coverage of the grafted area.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Guided bone regeneration (GBR)
A composite graft composed of a 50:50 proportion of autogenous bone and a demineralized bone mineral will be positioned around the bony defect or placed in the membrane, depending on the group randomization. The selected membrane will then be secured with screws to ensure a complete and stable coverage of the grafted area.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Physical status according to the American Society of Anesthesiology (ASA) I or II, which includes patients who are systematically healthy or may suffer from mild to moderate, however well-controlled systemic diseases.
* Subjects having at least one free end saddle edentulous area of the posterior area of the mandible with moderate horizontal and vertical bone defects \>≥3mm.
* Capacity to understand and accept the written conditions of the study.
Exclusion Criteria
* Smoking habit of \>10 cigarettes/day (self-reported).
* Abuse of alcohol or drugs.
* Pregnancy or individuals attempting to get pregnant (self-reported).
* Acute local or systemic infections.
* Uncontrolled diabetes or other metabolic disease.
* Severe hepatic or renal dysfunction.
* Autoimmune disorders.
* Patients who underwent radiotherapy in the last 5 years.
* Patients undergoing immunosuppressive therapy or who are immunocompromised.
* Any other contraindications for undergoing surgery.
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Michigan
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Hom-Lay Wang, DDS, MSD, Ph D
Collegiate Professor of Periodontics and Professor of Dentistry
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Hom-Lay Wang, DDS MSD PhD
Role: PRINCIPAL_INVESTIGATOR
Department of Periodontics and Oral Medicine, University of Michigan
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Michigan School of Dentistry
Ann Arbor, Michigan, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
HUM00262750
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.